Zhao Jing, Xu Yaming, Zong Yijia, Zhang Shiyun, Song Yichao, Yu Kangkang, Li Zhe, Ji Yonghua, Qiu Yongming, Chen Fuxue
School of Life Sciences, Shanghai University, Shanghai, China.
Hematology. 2011 Jul;16(4):232-5. doi: 10.1179/102453311X13025568941925.
Acute myeloid leukemia (AML) is the most common myeloid leukemia. It is highly malignant, thus, most patients with AML will relapse and die after traditional treatment. Stat3, a member of the signal transducer and activator of transcription (Stat) family, is involved in the development and progression of many tumors. The purpose of the study was to investigate whether the down-regulation of Stat3 expression by RNA interference is effective against human leukemia HL-60 cells. The results indicated that constitutively expressed Stat3 is present in human leukemia HL-60 cells, and the down-regulation of Stat3 expression caused significant induction of apoptosis as well as inhibition of proliferation in HL-60 cells. These data further demonstrated that Stat3 plays a critical role in human leukemia HL-60 cell apoptosis and proliferation. Thus, targeting Stat3 may be a useful adjunctive treatment strategy in AML.
急性髓系白血病(AML)是最常见的髓系白血病。它具有高度恶性,因此,大多数AML患者在传统治疗后会复发并死亡。信号转导和转录激活因子(Stat)家族成员Stat3参与多种肿瘤的发生和发展。本研究的目的是探讨通过RNA干扰下调Stat3表达对人白血病HL-60细胞是否有效。结果表明,人白血病HL-60细胞中存在组成性表达的Stat3,下调Stat3表达可显著诱导HL-60细胞凋亡并抑制其增殖。这些数据进一步证明Stat3在人白血病HL-60细胞凋亡和增殖中起关键作用。因此,靶向Stat3可能是AML中一种有用的辅助治疗策略。